Cargando…
Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology
C1q TNF Related Protein 3 (CTRP3) is a member of a family of secreted proteins that exert a multitude of biological effects. Our initial work identified CTRP3’s promise as an effective treatment for Nonalcoholic fatty liver disease (NAFLD). Specifically, we demonstrated that mice fed a high fat diet...
Autores principales: | Li, Ying, Ozment, Tammy, Wright, Gary L., Peterson, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058508/ https://www.ncbi.nlm.nih.gov/pubmed/27727322 http://dx.doi.org/10.1371/journal.pone.0164593 |
Ejemplares similares
-
Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease
por: Li, Diandian, et al.
Publicado: (2015) -
The adipokine C1q TNF related protein 3 (CTRP3) is elevated in the breast milk of obese mothers
por: Kwon, Megan R., et al.
Publicado: (2018) -
Expression of CTRP3, a Novel Adipokine, in Rats at Different Pathogenic Stages of Type 2 Diabetes Mellitus and the Impacts of GLP-1 Receptor Agonist on It
por: Li, Xin, et al.
Publicado: (2014) -
Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals
por: Wang, Wenqing, et al.
Publicado: (2016) -
Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury
por: Sadat‐Ebrahimi, Seyyed‐Reza, et al.
Publicado: (2022)